N/A
N=48
Percutaneous Microelectrolysis on Myofascial Trigger Points Pain.
Myofascial Trigger Point Pain (MTrP)
Bottom Line
View on ClinicalTrials.gov: NCT03636386 ↗Enrolled (actual)
48
Serious AEs
0.0%
Results posted
Apr 2020
Primary outcome: Primary: Pain Pressure Threshold (PPT) — 1.4; 1.4; 1.6; 1.6 Kg/cm2
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Percutaneous microelectrolysis (Device); Ultrasound therapy (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Quiropraxia y Equilibrio
- Primary completion
- Dec 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pain Pressure Threshold (PPT) |
1.4; 1.4; 1.6; 1.6; 1.7; 1.6 | — |
| SECONDARY Pain Intensity (PI) |
32.1; 31.4; 24.6; 24.8; 21.6; 23.8 | — |
Summary
The aim of the design is to investigate the value of percutaneous microelectrolysis (MEP) as an analgesic technique in myofascial trigger points. This research seeks to evaluate influence of cathode polar effects on the reduction of painful pressure (PPT) threshold and pain intensity (PI) in the myofascial trigger points (MTrPs) of upper trapezius muscle. An assessment with algometry and visual analog scale (VAS) will be made before applying the intervention. The study will evaluate changes in PPT and PI in a group exposed to percutaneous microelectrolysis (MEP) aplication compared to control group. Both groups will be provided with a baseline treatment of therapeutic ultrasound. Treatment will include three evaluation sessions. Subsequently, researchers will proceed to compare PPT and PI obtained from algometry test and VAS in each groups, and between groups, before and after the intervention. Changes obtained between sessions will be compared.
Eligibility Criteria
- Inclusion criteria
- Students of Sciences Rehabilitation Faculty.
- Participants over 18 years old.
- Participants presenting Hypersensitive Pain Points (Trigger Points) at level of upper trapezius muscle. The positive trigger point (+) will be the presence of pain at a pressure of less than 3kg/cm2 at muscle point.
- Exclusion criteria
- Musculoskeletal problems or pathologies of the neck or shoulders in the last 6 months (fractures, sprains, tendinopathies, dislocations, muscle tears, etc.).
- Participants who present cervical pain.
- Presence of osteosynthesis materials near shoulders, neck or surrounding areas
- Alterations of sensitivity such as hypesthesia, anesthesia or hyperesthesia in the neck, shoulders and / or arms
- Presence of wounds or skin alterations in the shoulder region (psoriasis, scars, keloids).
- Apprehension or fear of electrotherapy aplication.
- Ingestion of medications or analgesic pharmacological treatment at time of recruitment (Non-steroidal anti-inflammatory or steroidal).
- Elimination Criteria
- Non-tolerance of electrotherapy intervention that requires suspension of treatment.
- Non-completion of evaluation protocol (attendance at all scheduled sessions).
Data sourced from ClinicalTrials.gov (NCT03636386). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.